• © Goverland Inc. 2026
  • v1.0.8
  • Privacy Policy
  • Terms of Use
Quantum Biology DAOQuantum Biology DAOby0x47ed3D53A39287eE73E519512b42c7cE95039aB70x47ed…9aB7

Quantum Biology DAO DP-25 — Six Month Grant to Quantum Biology Institute Proposal, v1.7

Voting ended 16 days agoSucceeded

This is Phase 3 of DAO governance. Voting is token-weighted using the QBIO token, which are available on Uniswap.

The following proposal is marked "normal" and as such will be in Phase 3 in Snapshot for 3 days. Votes will be taken into account if posted before 4:30pm PT | 7:30pm ET | 12:30am GMT | 1:30am GMT+1 on Sun Apr 19 2026 PT/ET.

———

Quantum Biology DAO “Six Month Grant to Quantum Biology Institute” Proposal, v1.7

Quantum Biology DAO Development Proposal - 025 (QBIO DP-25)

Title: Quantum Biology DAO “Six Month Grant to Quantum Biology Institute” Proposal

For full text, see original drafted text or public discussion.

Summary

This development proposal provides up to $1.2 million USD in funding for the Quantum Biology Institute (QBI), composed of $1.05 million USD in a direct grant and up to $150,000 USD in matching funds, for the six month period May 1, 2026 through October 31, 2026. QBI will provide monthly updates to the DAO on its activities, which are primarily research, though also include an educational component as part of fundraising. Within two weeks of receiving the grant, QBI will host a community meeting to discuss how it plans to achieve its objectives, research roadmap and fundraising strategy. QBI will permit DAO visiting researchers to use its facilities, so long as this is compatible with QBI’s operation. Provisions are made in case QBI misses its targets or is unable to raise funds independently. An agreement over IP will be reached by the end of the third month of the grant period. Also, incorrect payments from the DAO to QBI are corrected.

Background

See drafted text or public discussion.

Description

1. Definition of the “grant period.” The grant period for the DAO’s grant to QBI is the six month period from May 1, 2026 until October 31, 2026.

2. Approval of $1,050,000 USD grant for QBI. The Quantum Biology DAO will grant $1,050,000 USD equivalent to the Quantum Biology Institute. This grant will cover Institute operations during the grant period. QBI’s projected budget for 2026 is publicly available, as is its previous spending.

3. Approval of $150,000 USD matching funds for QBI. Additionally, the Quantum Biology DAO will grant up to $150,000 USD equivalent to QBI, matching external donations on a 1:1 basis. Donations by QBI beneficiaries are not eligible for matching.

4. Disbursement schedule. Disbursements for the grant will be made in accordance with the following schedule:

  • May 1, Jun 1, Jul 1 — $200,000 USD equivalent per month

  • Aug 1, Sep 1, Oct 1 — $150,000 USD equivalent per month.

Grants may be disbursed up to two weeks in advance of the scheduled date.

5. Disbursement details. At the time of disbursement, the DAO will transfer the requisite amount of USDC, a USD equivalent, from the DAO treasury to QBI’s Coinbase account. Prior to disbursement, the DAO will take any treasury actions, if necessary, to ensure that the requisite amount of USDC is available for transfer.

6. Repayment of overdrawn funds. As noted in the Background, QBI mistakenly overdrew $326,637.05 from its 500 ETH grant. Within the first three months of the grant described by this proposal, i.e., by Jul 31, 2026, QBI shall repay the DAO for the $326,637.05 in overdrawn funds. Funds for this repayment may come from the disbursements described in point 4 above, with the effect of lowering the total amount of money given out through this grant.

7. Accounting for remaining ETH on previous grant. QBI has 28.98 ETH remaining on the 500 ETH grant (DP-20). QBI and the DAO will continue to manage this ETH as described by previous proposals, including DP-20 and DP-21. The DAO will also take special effort to ensure that its records of that grant are accurate.

8. Reconciliation of further discrepancies. If further significant discrepancies are discovered between QBI and the DAO’s accounting, these will be resolved by constructing the history in accordance with the original intention of the agreements, insofar as that can be ascertained, and otherwise in an equitable manner agreeable to both parties.

9. Transparency of finances. QBI shall continue its public reporting as it has done under the 500 ETH grant (DP-20) with at least the level of transparency as it has achieved previously. Furthermore, at the DAO’s request, within seven days, any aspects of QBI’s finances shall be made available to DAO Core Contributors so that they may be shared with DAO members for review.

10. QBI research efforts. Apart from its fundraising efforts, the vast majority of QBI’s efforts during the grant period will be to advance QBI’s research plans, with the overarching goal of achieving the direct measurement of quantum states inside cells at room temperature. QBI’s research program is described in Appendix I.

11. QBI public education efforts. As part of its fundraising efforts, QBI will produce public education content according to the schedule stated in Appendix II (point 5).

12. Monthly QBI reporting to the DAO. In order to ensure QBI performance, QBI will present to the DAO each month. In each presentation, QBI will report on its use of funds, research output, updates to its research plan, KPI dashboard, partnership and collaboration updates, and fundraising efforts. QBI will also assist the DAO with its monthly reports to Bio Protocol (cf. Bio’s beta platform). More information about QBI’s accountability requirements are included below in Appendix II (points 4, 6, and 7).

13. DAO visiting researchers. During the grant period and for six months afterwards, QBI will welcome DAO-sponsored visiting researchers at the lab. DAO-sponsored visiting researchers will be permitted to use QBI’s space and infrastructure, insofar as that use is compatible with QBI’s operation and research aims. Alessandro Lodesani, QBI COO and DAO co-founder, will determine whether and when this is compatible with QBI’s plans to ensure that DAO visiting researchers do not interfere with QBI’s operation.

14. Penalties for missed targets. If QBI misses targets, as specified in Appendix II (points 4, 6, 7, and 8), the DAO may choose to reduce QBI’s funding for the latter half of the granting period, i.e., Jul 1-Oct 31.

15. Asset management in the event of QBI funding shortfall. For the grant period and nine months afterwards, if QBI monthly spend falls below $40,000 USD in two different months, consecutive or non-consecutive, then all QBI assets acquired during the period of DAO grants to QBI, including previous DAO grants, may be utilized or disposed of as the DAO wishes, with proceeds from asset sales returning to the DAO. If a special circumstance arises, QBI may appeal to the DAO to amend this point.

16. Non-transfer of DAO assets. During the grant period and the nine months afterwards, QBI will not sell or transfer ownership of QBI assets in order to raise funds without the express permission of the DAO.

17. IP division to be determined within three months. By July 31st, QBI and the DAO will reach an agreement about the division of IP generated by QBI’s efforts as funded by the DAO. This agreement will be reached through proper channels at the DAO with appropriate participation from QBI, the DAO, and available DAO stakeholders.

Reaching an agreement on IP by July 31, 2026 is a requirement for the continuation of this grant for the remaining three months. This is provided all parties exercise best efforts to reach an agreement. Best efforts means taking all reasonable steps and working with the same level of care and persistence to get the negotiation completed.

The grant will be discontinued if an agreement is not reached and QBI does not exercise best efforts; the grant will not be discontinued if an agreement is not reached and the DAO does not exercise best efforts. DAO stakeholders that do not exercise best efforts will be excluded from negotiations, at the discretion of the DAO.

18. Positive QBI/DAO relationship. Interactions between QBI and the DAO are expected to be collaborative, with all sides acting honestly, reasonably, cooperatively, and in good faith, especially given the organizations’ overlapping missions and shared history. Negotiations conducted between QBI and the DAO, including the IP negotiation, are expected to be conducted in this spirit, with all sides making best efforts to find arrangements that treat all parties fairly and avoid well-known problems.

19. Provision for DAO treasury shortfall. In the event that the value of assets in the DAO’s treasury, which at this time are ETH, USDC, QBIO, and PAXG, fall dramatically, it may be necessary for QBI to submit a revised proposal. If such events transpire, the DAO will contact QBI in a timely manner.

Statement

See drafted text or public discussion.

Off-Chain Vote

For
176.95M QBIO100%
Against
0 QBIO0%
Abstain
49.97K QBIO0%
Quorum:1311%
Download mobile app to vote

Discussion

Quantum Biology DAOQuantum Biology DAO DP-25 — Six Month Grant to Quantum Biology Institute Proposal, v1.7

Timeline

Apr 16, 2026Proposal created
Apr 16, 2026Proposal vote started
Apr 19, 2026Proposal vote ended
Apr 20, 2026Proposal updated